Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

10.5%

2 terminated/withdrawn out of 19 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

37%

7 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

Phase 4
7(43.8%)
Phase 2
4(25.0%)
N/A
3(18.8%)
Phase 1
2(12.5%)
16Total
Phase 4(7)
Phase 2(4)
N/A(3)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT05679570Phase 2Active Not Recruiting

Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)

Role: collaborator

NCT06913907Phase 4Recruiting

Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)

Role: lead

NCT03505008Phase 4Completed

Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan

Role: lead

NCT06814873Not ApplicableCompleted

Enhanced Human Sensorimotor Integration Via Self-modulation of the Somatosensory Activity

Role: lead

NCT06014801Phase 2Recruiting

Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients

Role: collaborator

NCT06554145Recruiting

Development and Evaluation of AI Program for Predicting Bacterial Species From Urine Gram Stain Specimens

Role: collaborator

NCT06519032Recruiting

Development and Evaluation of Rapid Bacterial Species Identification for Acid-Fast Bacilli Smear Using Image Analysis AI

Role: collaborator

NCT04637191Not ApplicableCompleted

Cognitive Function Evaluation and Rehabilitation by a Digital Game: MentalPlus®

Role: collaborator

NCT04546074Phase 1Unknown

Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma

Role: lead

NCT01895517Phase 4Completed

CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening (CITRUS Study)

Role: collaborator

NCT04699994Phase 2Unknown

Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel

Role: lead

NCT01555840Not ApplicableCompleted

Comparative Study of the Magnetically Guided Capsule Endoscopy Versus High Definition Gastroscopy

Role: collaborator

NCT00247130Phase 4Withdrawn

Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer

Role: lead

NCT00270881Phase 1Completed

Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies

Role: lead

NCT01270035Phase 4Unknown

Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate

Role: lead

NCT00716248Phase 4Unknown

Bucillamine Study of Holding Remission After Infliximab Dose-off

Role: collaborator

NCT00369148Phase 4Completed

Combination of Glinides With Premixed Insulin

Role: lead

NCT00920179Unknown

Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome

Role: lead

NCT00367497Phase 2Terminated

Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

Role: lead

All 19 trials loaded